Short-Term Outcomes of Conventional versus VATS Lobectomy in Surgical Treatment of NSCLC | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 101, Volume 90, Issue 2, January 2023, Page 2656-2661 PDF (498.16 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2023.286418 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Abdelhamid Fathi Sherif  ; Rakan Khalifa; Anhar Elsayed Abd-Ellatif
| ||||
| Abstract | ||||
| Background: A major cause of cancer-related death is non-small-cell lung cancer (NSCLC). As only 20 % of NSCLC cases are typically discovered while the illness is potentially curable & resectable, resulting in poor 5-year survival rate. Objective: To compare between conventional versus VATS lobectomy in surgical treatment of NSCLC. Patients and Methods: This prospective randomized open label clinical trial involved 100 patients aged >18 years old sex diagnosed with NSCLS at Benha university. Randomly, cases were classified into 2 equal groups by computer generator into group A (n=50): underwent open thoracotomy, and group B (n=50): underwent VATS. All patients were subjected to full history taking, general examination such as vital signs and laboratory investigations were recorded. Results: Group A had significant increased duration of operation, prolonged air leak, & atelectasis than group B (P value <0.001, 027, 0.030 respectively). Pneumonia, hemothorax, AF, cerebrovascular accident and wound infection were insignificantly different between both groups. Group B had significant lower ICU stay & hospital stay than group A. Bleeding, readmission, recurrence, and mortality were insignificantly different between both groups. Group B had significant higher mean survival rate than group A. Conclusion: Open lobectomy was accompanied with a reduced survival rate and more comorbidities than VATS lobectomy. These findings imply showed that for treating NSCLC at an early stage, VATS is a safe & efficient method. | ||||
| Keywords | ||||
| Conventional; VATS; Open thoracotomy; Surgical treatment; NSCLC | ||||
|
Statistics Article View: 87 PDF Download: 240 |
||||
